ADVISORY/Experts Available to Discuss Study Showing that Fruits, Vegetables Lower Breast Cancer Risk.

Business Editors

ADVISORY...

--(BUSINESS WIRE)

TOPIC: A study found women who consume at least four servings of fruits and vegetables per day lower their breast cancer risk by 50 percent compared to women who only eat two servings per day, according to an article by HealthDayNews. Researchers from Oregon Health and Science University compared the diets of 378 women who have breast cancer with 1,070 women who do not have the disease. The study was presented at the American Association for Cancer Research conference in Phoenix this week.

EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story:

Dr. Joyce O'Shaughnessy is currently a breast cancer researcher and practitioner at Texas Oncology, P.A. in Dallas and is Associate Director for clinical research for US Oncology. She is also Director, Chemoprevention Research and Co-Director, Breast Cancer Research for US Oncology. Dr. O'Shaughnessy's major area of research interest is the development of breast cancer, and she is involved in several ongoing chemoprevention studies. Dr. O'Shaughnessy did her internship and residence in internal medicine at Massachusetts General Hospital, followed by her fellowship in medical oncology at the National Cancer Institute (NCI). She served as special assistant to the NCI director from 1988 to 1990 and coordinated the development of new cancer drug approval guidelines for the NCI and Food and Drug Administration. Dr. O'Shaughnessy then served as a Senior Investigator in the Medical Breast Cancer Section of the NCI from 1990 through 1995. In this role, she conducted many breast cancer treatment clinical trials, including evaluation of high-dose chemotherapies and hematopoietic growth factors, new cytotoxic drug combinations, novel hormonal treatments, monoclonal antibody and gene therapies for breast cancer. Dr. O'Shaughnessy also has served as principal investigator on several tissue-based breast cancer prevention clinical trials involving the administration of fenretinide, tamoxifen, and other SERMs to women at high risk for the development of breast cancer. Dr. O'Shaughnessy has been published and spoken widely on new prevention and treatment strategies for breast cancer. 214-370-1000, [e-mail]

Dr. Brian Kaplan, a surgical oncologist at Virginia Commonwealth University's MCV Hospitals, is an expert regarding health sciences and breast cancer. 804-828-3250

Dr. Timothy Lash is an Assistant Professor in the Department of Epidemiology at the Boston University School of Public Health. He has expertise in epidemiology, biostatistics, and molecular biology. He currently teaches a course on modern epidemiologic methods. He has also taught health risk assessment and introductory epidemiology. Dr. Lash's research interests focus on the etiology and treatment of breast cancer. 617-638-8384

ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue.

ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/.